Williams Jones Wealth Management, Llc. Biogen Inc. Transaction History

Williams Jones Wealth Management, Llc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $6,455 - $7,770	-29 Reduced 2.27%	1,247 $322,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $26,596 - $30,018	-105 Reduced 7.6%	1,276 $327,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $7,440 - $8,477	-29 Reduced 2.06%	1,381 $383,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $10,123 - $13,959	52 Added 3.83%	1,410 $377,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $47,822 - $56,870	255 Added 23.12%	1,358 $277,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1,162 - $1,464	6 Added 0.55%	1,103 $232,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5,598 - $7,194	-25 Reduced 2.23%	1,097 $263,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $18,111 - $23,619	-64 Reduced 5.4%	1,122 $318,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $1,295 - $2,073	-5 Reduced 0.42%	1,186 $411,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $51,977 - $78,238	-220 Reduced 15.59%	1,191 $292,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $306,807 - $344,114	1,411 New	1,411 $329,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.